U.S. issues initial Medicare drug price negotiation guidance
By Ahmed Aboulenein and Michael Erman WASHINGTON (Reuters) -The U.S. government will select the Medicare program’s 10 costliest prescription medicines based on gross spending for negotiating price cuts that will go into effect in 2026, the U.S. Centers for Medicare and Medicaid Services (CMS) said on Wednesday CMS will only accept one formal written counter …
U.S. issues initial Medicare drug price negotiation guidance Read More »